- 2 -

Similar documents
한약재품질표준화연구사업단 금은화 ( 金銀花 ) Lonicerae Flos 생약연구과

한약재품질표준화연구사업단 단삼 ( 丹參 ) Salviae Miltiorrhizae Radix 생약연구과

한약재품질표준화연구사업단 작약 ( 芍藥 ) Paeoniae Radix 생약연구과

한약재품질표준화연구사업단 고삼 ( 苦參 ) Sophorae Radix 생약연구과

한약재품질표준화연구사업단 강활 ( 羌活 ) Osterici seu Notopterygii Radix et Rhizoma 생약연구과

한약재품질표준화연구사업단 맥문동 ( 麥門冬 ) Liriopis Tuber 생약연구과



한약재생리활성성분의분리및분석연구 ( 금은화, 인동 ) 서울대학교 식품의약품안전청

환경중잔류의약물질대사체분석방법확립에 관한연구 (Ⅱ) - 테트라사이클린계항생제 - 환경건강연구부화학물질연구과,,,,,, Ⅱ 2010

歯140김광락.PDF

최종보고서_경기과학기술진흥원 김진규_ hwp

- 1 -

이 발명을 지원한 국가연구개발사업 과제고유번호 G 부처명 한국환경산업기술원 연구사업명 토양지하수오염방지기술개발사업 연구과제명 시데로포아(Siderophore)의 대량생산을 통한 토양 및 지하수의 친환경 중금속 제거기술 개 발

84-01.fm

DBPIA-NURIMEDIA

lastreprt(....).hwp

Statistical Data of Dementia.

51(2)-06.fm

<4D F736F F F696E74202D20BFEBB1E2C6F7C0E5BAD0BCAEB9FDB1B3C0B02DC7EDBCBEBFC1C5D9>

- 2 -

25(6)-21(김유곤).fm

1. 빨리 출되는 매에서 검출되는 시를 체. 이 단계에서 칼 없이 직접 검출에 연결하여 시의 검출 체. 2. 메탄올과 이 혼합된 이동상을 이하여 C18에서 시의 출을 체하고 시의 탄소 수 및 와 된 참고 참고. 3. 이동상의 메탄올 양을 변화시키면서 k 값을 2-20

- 2 -

- 1 -

063~078 인삼

유해중금속안정동위원소의 분석정밀 / 정확도향상연구 (I) 환경기반연구부환경측정분석센터,,,,,,,, 2012

DBPIA-NURIMEDIA

(2) : :, α. α (3)., (3). α α (4) (4). (3). (1) (2) Antoine. (5) (6) 80, α =181.08kPa, =47.38kPa.. Figure 1.

최은옥인하대학교식품영양학과 1. 1,200, %, 50%,, -linolenic acid. (linseed oil; 38%)..,, ( 1998),, (, 1998).,., -3/ -6,,,,. 433

26(1)-11(김기준).fm

82-01.fm

033~50 ¿ŁÃ³¸® ¹×


슬라이드 1

Subject : 귀사의 일익번창하심을 진심으로 기원합니다.


82.fm

개최요강

특허청구의 범위 청구항 1 Na-알지네이트(Na-alginate), 합성 제올라이트(synthetic zeolite)와 분말활성탄(powdered activated carbon) 을 혼합하여 2 ~ 6 %의 CaCl 2 용액에서 경화시켜 만들어진 직경 1 ~ 5 mm의

저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할


최종보고서 /

<C3CA3520B0FAC7D0B1B3BBE7BFEB202E687770>

08.fm

e hwp

- 1 -

이주형.PDF

저작자표시 - 동일조건변경허락 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 이차적저작물을작성할수있습니다. 이저작물을영리목적으로이용할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원

83-07.fm

목차 ⅰ ⅲ ⅳ Abstract v Ⅰ Ⅱ Ⅲ i

주관기관 냄새환경학회 국립환경과학원

untitled

(Microsoft PowerPoint - src.ppt [\300\320\261\342 \300\374\277\353] [\310\243\310\257 \270\360\265\345])

012임수진

연구배경및목적 연구배경 연구목적

PowerPoint 프레젠테이션

00....

94 Chap 17 : Carboxylic Acids 17.1 Structure 17.2 Nomenclature 17.3 Physical properties 17.4 Acidity 17.5 Preparation of carboxylic acids 17.6 Reducti

4. Desorbed amount of formaldehyde diffusive sampler was increased by high relative humidity. 5. Wheth diffusive samplers were stored at room temperat

Quantitative Chemical Analysis 8 th Ed. - Daniel C. Harris 제 22 장 Introduction to Analytical Separations

달생산이 초산모 분만시간에 미치는 영향 Ⅰ. 서 론 Ⅱ. 연구대상 및 방법 達 은 23) 의 丹 溪 에 최초로 기 재된 처방으로, 에 복용하면 한 다하여 난산의 예방과 및, 등에 널리 활용되어 왔다. 達 은 이 毒 하고 는 甘 苦 하여 氣, 氣 寬,, 結 의 효능이 있

약학석사학위논문 섬괴불나무의화학성분 Chemical Constituents from Lonicera insularis 2017 년 2 월 서울대학교대학원 약학과생약학전공 김미송

Precipitation prediction of numerical analysis for Mg-Al alloys

발아벼 항당뇨_최종보고서.hwp

14.fm

저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할

Title: Biacore getting started kit 를이용한 KD 값도출방법 목차 1. 실험목적 2. 실험개요와필요한시약및소모품 2.1 실험개요 2.2 필요한시약및소모품 3. 실험방법과결과 3.1 ph-scouting for pre-concentration

포스코 사회공헌 활동 백서 2003_2006

(01) hwp

84-07.fm


슬라이드 제목 없음

DBPIA-NURIMEDIA

93-09.fm

01_°íºÀÂùöKš

Journal of Life Science 2011, Vol. 21. No μ μ

<B3EDB9AE20BCD3C7A5C1F62E687770>

Microsoft PowerPoint - d ppt [호환 모드]

sensitive 최상의감도제공 simple 간편한사용법과유지관리 small 어떠한 LC 와도사용가능 Grace Davison Discovery Sciences Brochure #531K From the Leader in Evaporative Light Scatteri

Analysis of objective and error source of ski technical championship Jin Su Seok 1, Seoung ki Kang 1 *, Jae Hyung Lee 1, & Won Il Son 2 1 yong in Univ

Introduction Capillarity( ) (flow ceased) Capillary effect ( ) surface and colloid science, coalescence process,

16(2)-3(p ).fm

-, BSF BSF. - BSF BSF ( ),,. BSF -,,,. - BSF, BSF -, rrna, BSF.

表紙(化学)

< C6AFC1FD28B1C7C7F5C1DF292E687770>

QbD 적용을위한품질심사해설서 ( 예시 )

DBPIA-NURIMEDIA

년AQM보고서_Capss2Smoke-자체.hwp

8-VSB (Vestigial Sideband Modulation)., (Carrier Phase Offset, CPO) (Timing Frequency Offset),. VSB, 8-PAM(pulse amplitude modulation,, ) DC 1.25V, [2

PDF

untitled

untitled

PowerPoint 프레젠테이션

Chapter 11 Rate of Reaction

(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re

139~144 ¿À°ø¾àħ

07.051~058(345).fm

44-3대지.08류주현c

untitled

Transcription:

한약재품질표준화연구사업단 인동 ( 忍冬 ) Lonicerae Folium et Caulis 생약연구과

- 2 -

KP 11 Lonicera japonica Thunberg 0.1% CP 2015 JP 16 Lonicera japonica Thunberg chlorogenic acid 0.10% Lonicera japonica Thunberg - β α - 3 -

α α β β α α β β α β α α α α β β β α β β α α β α α β β α α β β α β β β α α α β β β α β β - 4 -

Lonicera japonica Thunberg (Leaf and Stem) - 5 -

Lonicera japonica Lonicera japonica ( ),, ( ), ( ), ( ), ( ), ( ),, ( ),, ( ),, 70% EtOH ( %) 16 g (16%) 12.5 g (12.5%) 38.8 g (38.8%) 17.6 g (17.6%) 39.3 g (39.3%) 14.0 g (14.0%) 17.7 g (17.7%) 13.2 g (13.2%), 70% EtOH - - - 6 -

- 7 -

- 8 -

- 9 -

- 10 -

- 11 -

(mg) hydrocarbon alcohol (docosanol + tetracosanol) (1) 3, *hydrocarbon alcohol (docosanol + tetracosanol + eicosanol) (2) 4, *24(S )-cycloart-25-en-3β,24-diol (3) 5, *trilinolein (4) 20, *n-hexacosanol (5) 212, *obtusifoliol (6) 2, *gramisterol (7) 2, *citrostadienol (8) 3, *β-sitosterol (9) 1,126, *DOP[bis(2-ethylhexyl)phthalate] (10) 30, fatty acids (11) 46, *coniferaldehyde (12) 10, *caffeic acid docosanoyl ester (13) 13, *pomolic acid (14) 8, *ursolic acid (15) 20, *9α-hydroxypinoresinol (16) 5, *euscaphic acid (17) 10, *hederagenin (18) 10, secologanin dimethyl acetal (19) 256, *daucosterol (20) 98, *23-hydroxytormentic acid (21) 16, caffeic acid (22) 7, *9,12,13-trihydroxyoctadeca-10(E),15(Z)-dienoic acid (23) 17, *pinellic acid (24) 10, *7,8-threo-4,7,9,3',9'-pentahydroxy-3-methoxy-8-O-4'-neolignan (25) 2, **5-demethxyl-3-methoxyisolariciresinol (26) 2, *pinoresinol 4-O-glucoside (27) 105, sweroside (28) 1,232, *coniferylaldehyde 4-O-glucoside (29) 4, *linarin (30) 2, *coniferin (31) 120, - 12 -

loganin (32) 6,526, *loganic acid (33) 304, *demethylsecologanol (34) 2, - 13 -

(compound number) hydrocarbon alcohol (docosanol + tetracosanol) (1) *hydrocarbon alcohol (docosanol + tetracosanol + eicosanol) (2) *24(S)-cycloart-25-en-3β,24-diol (3) *trilinolein (4) *n-hexacosanol (5) *obtusifoliol (6) *gramisterol (7) *citrostadienol (8) - 14 -

*β-sitosterol (9) *DOP[bis(2-ethylhexyl)phthalate] (10) fatty acids (11) *coniferaldehyde (12) *caffeic acid docosanoyl ester (13) *pomolic acid (14) *ursolic acid (15) *9α-hydroxypinoresinol (16) - 15 -

*euscaphic acid (17) *hederagenin (18) secologanin dimethyl acetal (19) *daucosterol (20) *23-hydroxytormentic acid (21) caffeic acid (22) - 16 -

*9,12,13-trihydroxyoctadeca-10(E),15(Z)-dienoic acid (23) *pinellic acid (24) *7,8-threo-4,7,9,3',9'-pentahydroxy-3-methoxy -8-O-4'-neolignan (25) **5-demethxyl-3-methoxy isolariciresinol (26) *pinoresinol 4-O-glucoside (27) sweroside (28) *coniferylaldehyde 4-O-glucoside (29) *linarin (30) - 17 -

*coniferin (31) loganin (32) *loganic acid (33) *demethylsecologanol (34) β - 18 -

α β α β β α - 19 -

Lonicerae Folium - 20 -

Table 2. TLC condition Compounds Mobile phase Detection TLC plate coniferin, loganic acid, demethylsecologanoside, sweroside, loganin EtOAc : MeOH : H 2 O (5.2 : 2.8 : 0.8) H 2 SO 4, MeOH : H 2 O (55 : 45) FeCl 3, I 2 Normal (Silica) Reverse (ODS) <FeCl3> 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 14 15 16 17 18 19 20 21 1 2 3 4 5 22 23 24 25 26 27 28 29 <H 2 SO 4 > 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 14 15 16 17 18 19 20 21 <I 2 > 1 2 3 4 5 22 23 24 25 26 27 28 29 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 22 23 24 25 26 27 28 29 1 2 3 4 5 14 15 16 17 18 19 20 21 Fig. 4. Thin layer chromatography in silica gel plate of 24 Lonicerae Folium samples Marker compounds; 1. coniferin 2. loganic acid 3. demethylsecologanoside 4. sweroside 5. loganin (6. Uijeongbu, gyeonggi 7. Hong-cheon, gang-won 8. Gimpo, gyeonggi 9. Cheong-song, gyung book 10. Pocheon, gyeonggi 11. Wansan, yeongcheon 12. Hwasan, yeongcheon 13. Yong-mun, yangpyung 14. Sang-ju, gyung book 15. An-dong, gyung book 16. Yuseong, daejeon 17. Ganghwa 18. Dong-gu, daejeon 19. Gimcheon, gyung book 20. China 21. Gang-won 22. Bong-hwa, gyung book (stem) 23. Gyung-ju, gyung book (stem) 24. Gyung-ju, gyung book (leaf) 25. Seoul (stem) 26. Seoul (leaf) 27. Sandong, china (stem) 28. Sandong, china (stem) 29. Yeongcheon (stem)) - 21 -

<FeCl3> 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 14 15 16 17 18 19 20 21 1 2 3 4 5 22 23 24 25 26 27 28 29 <H 2 SO 4 > 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 14 15 16 17 18 19 20 21 <I 2 > 1 2 3 4 5 22 23 24 25 26 27 28 29 1 2 3 4 5 6 7 8 9 10 11 12 13 1 2 3 4 5 22 23 24 25 26 27 28 29 1 2 3 4 5 14 15 16 17 18 19 20 21 Fig. 5. Thin layer chromatography in ODS plate of 24 Lonicerae Folium samples Marker compounds; 1. coniferin 2. loganic acid 3. demethylsecologanoside 4. sweroside 5. loganin (6. Uijeongbu, gyeonggi 7. Hong-cheon, gang-won 8. Gimpo, gyeonggi 9. Cheong-song, gyung book 10. Pocheon, gyeonggi 11. Wansan, yeongcheon 12. Hwasan, yeongcheon 13. Yong-mun, yangpyung 14. Sang-ju, gyung book 15. An-dong, gyung book 16. Yuseong, daejeon 17. Ganghwa 18. Dong-gu, daejeon 19. Gimcheon, gyung book 20. China 21. Gang-won 22. Bong-hwa, gyung book (stem) 23. Gyung-ju, gyung book (stem) 24. Gyung-ju, gyung book (leaf) 25. Seoul (stem) 26. Seoul (leaf) 27. Sandong, china (stem) 28. Sandong, china (stem) 29. Yeongcheon (stem)) Table 3. The optimal condition of sample preparation Extracting method Solvent Time (Ultrasonication) 70% EtOH 30 μ μ μ μ μ μ - 22 -

Table 4. Analytical conditions of HPLC/DAD Column Shiseido Capcell Pak ODS UG120 (4.6 150 mm, 5 μm) Mobile phase A : H 2 O with 0.1% formic acid B : acetonitrile with 0.1% formic acid Flow rate 0.3 ml/min Column temp. 25 C Inj. vol. μl Time (min) Solvent (%B) 0 15 Gradient elution 10 20 30 35 35 40 35 15 DAD detector 250 nm μ - 23 -

Table 5. Optimum analytical conditions of HPLC Column Optimapak C18 (4.6 250mm) Mobile phase A: 10% aqueous methanol with 0.1% formic acid B: 90% aqueous methanol with 0.1% formic acid Flow rate 1.0 ml/min Column temp. C Inj. vol. 10 μl Time (min) Solvent (%B) 0 0 Gradient elution 15 30 25 70 30 35 70 100 (A) (B) Figure 6. HPLC chromatogram of mixed standard (A) and samples (B) of Lonicerae Folium et Caulis; 1. coniferin, 2. loganic acid, 3. sweroside, 4. loganin, 5. methylparaben - 24 -

μ μ μ μ μ μ μ μ μ μ μ - 25 -

Fig. 7. Distribution of (a) coniferin, (b) loganic acid, (c) sweroside and (d) loganin for Lonicerae Folium et Caulis samples - 26 -

α α α α α α μ α α μ μ μ μ α - 27 -

α α - 28 -

γ - 29 -

β β β α β β β β α β β β β α β β α β α β β α β α β β α - 30 -

β - 31 -

- 32 -

Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Column Optimapak C18 (4.6 250mm) A: 10% aqueous methanol with 0.1% formic acid Mobile phase B: 90% aqueous methanol with 0.1% formic acid Flow rate 1.0 ml/min Column temp. C Inj. vol. 10 μl Time (min) Solvent (%B) 0 0 Gradient elution 15 30 25 70-33 -

30 35 70 100 Ÿ Ÿ Ÿ Ÿ α - 34 -

γ - 35 -

( ) ( ) coniferin coniferin [ ]. loganic acid loganic acid (0.36%) [ ]. sweroside sweroside (0.41%) [ ]. loganin loganin (0.14%) [ ]. KP. coniferin, loganic acid, sweroside, loganin, coniferin. - 36 -

(Lonicerae Folium) KP Lonicerae Folium et Caulis Ÿ Lonicera japonica Thunberg JP Lonicerae Folium Cum Caulis Ÿ Lonicera japonica Thunberg CP Lonicerae Japonicae Caulis Ÿ Lonicera japonica Thunberg coniferin, loganic acid, sweroside, loganin 1 g 0.2 ml (methylparaben, 1 mg/ml) 9.8 ml 70% 30 ultrasonication 0.2 μm membrane filter 10 μl Detector ( ) Column ( ) Flow rate ( ) UV (254 nm) Optimapak C18 (4.6 250 mm) 1.0 ml/min Column temperature ( ) - Injection volume ( ) 10 μl Mobile phase ( ) Gradient (, B%) A : 10% aqueous methanol with 0.1% formic acid B : 90% aqueous methanol with 0.1% formic acid 0 15 : 0-30%, 15 25 : 30 70%, 25 30 : 70%, 30 35 : 70-100% coniferin loganic acid sweroside loganin 92 0.0191% 0.3640% 0.2360% 0.2710% KP ChP JP KP loganin 0.1% chlorogenic acid 0.1% loganic acid 0.36%, sweroside 0.41%, loganin 0.14% - 37 -

CH 2 Cl 2, CH 2 Cl 2 -MeOH - 38 -

성상 white powder 이명 [3-[(4-β-D-glucopyranosyloxy)-3-methoxyphenyl]-2-propenol,4-hydroxy-3 -methoxy-1-(γ-hydroxypropenyl)benzene-4-d-glucoside CAS number 531-29-3 분자식 C 16 H 22 O 8 (MW 342) 용해도 녹는점 ( ) 구조 - 39 -

δ δ ν α λmax (log ε) (MeOH) 212 (sh, 3.45), 258 (3.26), 265 (sh, 3.23) nm - 40 -

Column Shiseido Capell Pak ODS UG 120 C18 (5 μm, 150 mm 4.6 mm) Detector DAD (254 nm) Temp. 35 Injection volume - Flow rate 0.3 ml/min Mobile phase Time(min) H 2 O with 0.1% formic acid MeOH with 0.1% formic acid 0 80% 20% 15 65% 135% 25 35% 65% 30 35% 65% 35 80% 20% - 41 -

Analytes Linear range (μg/ml) Conversion equation r 2 LOD (ng/ml) LOQ (ng/ml) coniferin 1-20 Y = 0.18180X + 0.02239 0.99 0.557 1.687 Compounds Peak area ratio (peak area/is area) Retention time (min) Mean SD RSD (%) Mean SD RSD (%) coniferin 0.85 0.00 0.05 14.33 0.25 1.74 Compounds coniferin Spiked amount (μg) Intra-day (n=5) Inter-day (n=5) Recovery (%) RSD (%) Recovery (%) RSD (%) 2 101.19 0.45 100.62 0.45 4 100.08 0.20 100.18 0.26 8 99.90 0.23 100.72 0.27-42 -

Compounds Analytical condition Theoretical plate (N) Resolution capacity factor separation factor Shiseido 30260.00 ± 510.49 21.31 ± 0.13 1.18 ± 0.01 6.93 ± 0.13 Column phenomenex 39417.00 ± 514.85 19.34 ± 0.02 1.66 ± 0.00 2.69 ± 0.03 coniferin Column temp. Agilent 30822.00 ± 556.90 17.69 ± 0.05 1.51 ± 0.01 3.07 ± 0.00 25 31956.67 ± 458.50 17.62 ± 0.13 1.74 ± 0.01 2.70 ± 0.01 30 31946.00 ± 844.56 17.81 ± 0.15 1.61 ± 0.01 2.90 ± 0.02 35 29825.00 ± 596.92 17.41 ± 0.15 1.49 ± 0.01 3.15 ± 0.03 40 27732.00 ± 936.31 17.07 ± 0.27 1.37 ± 0.01 3.40 ± 0.03 45 26748.00 ± 102.68 16.83 ± 0.07 1.26 ± 0.01 3.66 ± 0.02 μ - 43 -

CH 2 Cl 2, CH 2 Cl 2 -MeOH loganic acid 성상 white powder 이명 β - 44 -

CAS number 22255-40-9 분자식 C 16 H 24 O 10 (MW 376) 용해도 녹는점 ( ) 구조 - 45 -

δ β α δ ν α β α λmax (log ε) (MeOH) - 46 -

Column Shiseido Capell Pak ODS UG 120 C18 (5 μm, 150 mm 4.6 mm) Detector DAD (254 nm) Temp. 35 Injection volume - Flow rate 0.3 ml/min Mobile phase Time(min) H 2 O with 0.1% formic acid MeOH with 0.1% formic acid 0 80% 20% 15 65% 135% 25 35% 65% 30 35% 65% 35 80% 20% - 47 -

Analytes Linear range (μg/ml) Conversion equation r 2 LOD (ng/ml) LOQ (ng/ml) loganic acid 1-20 Y = 0.02735X + 0.00282 1.00 0.327 0.990 Compounds Peak area ratio (peak area/is area) Retention time (min) Mean SD RSD (%) Mean SD RSD (%) loganic acid 0.52 0.00 0.09 15.90 0.29 1.81 Compounds loganic acid Spiked amount (μg) Intra-day (n=5) Inter-day (n=5) Recovery (%) RSD (%) Recovery (%) RSD (%) 2 105.89 3.15 102.50 1.99 4 100.87 1.96 100.88 0.96 8 100.00 0.56 100.10 0.58-48 -

Compounds Analytical condition Theoretical plate (N) Resolution capacity factor separation factor Shiseido 39002.00 ± 560.89 5.87 ± 0.02 1.48 ± 0.01 1.25 ± 0.00 Column phenomenex 44325.33 ± 553.77 4.09 ± 0.02 1.88 ± 0.01 1.13 ± 0.00 loganic acid Column temp. Agilent 37342.33 ± 403.20 4.75 ± 0.05 1.79 ± 0.01 1.18 ± 0.00 25 38317.00 ± 281.51 5.66 ± 0.06 2.09 ± 0.01 1.20 ± 0.01 30 37773.00 ± 1178.10 5.21 ± 0.08 1.69 ± 0.42 1.19 ± 0.00 35 36147.67 ± 637.27 4.68 ± 0.05 1.76 ± 0.01 1.39 ± 0.36 40 34245.33 ± 348.33 4.15 ± 0.03 1.61 ± 0.01 1.17 ± 0.00 45 31441.67 ± 1056.21 3.58 ± 0.01 1.46 ± 0.01 1.16 ± 0.00 μ - 49 -

CH 2 Cl 2, CH 2 Cl 2 -MeOH sweroside - 50 -

성상 white powder 이명 β CAS number 14215-86-2 분자식 C 16 H 22 O 9 (MW 358) 용해도 녹는점 ( ) 구조 - 51 -

δ δ ν α β α λmax (log ε) (MeOH) 240 (3.95) nm - 52 -

Column Shiseido Capell Pak ODS UG 120 C18 (5 μm, 150 mm 4.6 mm) Detector DAD (254 nm) Temp. 35 Injection volume μl Flow rate 0.3 ml/min Mobile phase Time(min) H 2 O with 0.1% formic acid MeOH with 0.1% formic acid 0 80% 20% 15 65% 135% 25 35% 65% 30 35% 65% 35 80% 20% - 53 -

Analytes Linear range (μg/ml) Conversion equation r 2 LOD (ng/ml) LOQ (ng/ml) sweroside 1-20 Y = 0.09848X + 0.00084 0.99 0.657 1.990 Compounds Peak area ratio (peak area/is area) Retention time (min) Mean SD RSD (%) Mean SD RSD (%) sweroside 2.28 0.00 0.03 22.05 0.27 1.21 Compounds sweroside Spiked amount (μg) Intra-day (n=5) Inter-day (n=5) Recovery (%) RSD (%) Recovery (%) RSD (%) 2 100.55 0.57 101.14 0.86 4 99.81 0.16 100.27 0.48 8 99.39 0.16 99.61 0.14-54 -

Compounds Analytical condition Theoretical plate (N) Resolution capacity factor separation factor Shiseido 57276.26 ± 624.36 10.94 ± 0.07 2.49 ± 0.01 1.38 ± 0.00 Column phenomenex 76078.33 ± 830.74 11.77 ± 0.03 2.82 ± 0.00 1.31 ± 0.01 sweroside Column temp. Agilent 57332.67 ± 132.40 12.21 ± 0.06 2.81 ± 0.01 1.32 ± 0.00 25 67969.33 ± 51.64 9.74 ± 0.12 3.10 ± 0.01 1.25 ± 0.00 30 59198.33 ± 1405.63 10.24 ± 0.12 2.94 ± 0.01 1.29 ± 0.01 35 56038.67 ± 762.36 10.82 ± 0.07 2.77 ± 0.01 1.32 ± 0.00 40 53077.67 ± 531.74 11.28 ± 0.03 2.61 ± 0.01 1.36 ± 0.01 45 49995.00 ± 1187.00 11.77 ± 0.13 2.46 ± 0.01 1.40 ± 0.00 μ - 55 -

- 56 -

CH 2 Cl 2, CH 2 Cl 2 -MeOH CH 2 Cl 2 -MeOH 성상 white powder 이명 β - 57 -

CAS number 18524-94-2 분자식 C 17 H 26 O 10 (MW 390) 용해도 녹는점 ( ) 구조 - 58 -

δ - 59 -

δ ν α β α - 60 -

Column Shiseido Capell Pak ODS UG 120 C18 (5 μm, 150 mm 4.6 mm) Detector DAD (254 nm) Temp. 35 Injection volume μl Flow rate 0.3 ml/min Mobile phase Time(min) H 2 O with 0.1% formic acid MeOH with 0.1% formic acid 0 80% 20% 15 65% 135% 25 35% 65% 30 35% 65% 35 80% 20% - 61 -

Analytes Linear range (μg/ml) Conversion equation r 2 LOD (ng/ml) LOQ (ng/ml) loganin 1-20 Y = 0.06499X + 0.01462 0.99 1.098 3.327 Compounds Peak area ratio (peak area/is area) Retention time (min) Mean SD RSD (%) Mean SD RSD (%) loganin 1.13 0.00 0.13 23.39 0.29 1.22 Compounds loganin Spiked amount (μg) Intra-day (n=5) Inter-day (n=5) Recovery (%) RSD (%) Recovery (%) RSD (%) 2 100.02 0.69 100.76 0.65 4 99.64 0.45 100.75 0.67 8 101.64 1.74 100.13 0.78-62 -

Compounds Analytical condition Theoretical plate (N) Resolution capacity factor separation factor Shiseido 92897.00 ± 1168.34 4.04 ± 0.03 2.70 ± 0.01 1.09 ± 0.00 Column phenomenex 123533.67 ± 1908.80 3.55 ± 0.01 3.00 ± 0.00 1.06 ± 0.00 loganin Column temp. Agilent 72175.33 ± 0.00 3.40 ± 0.01 3.02 ± 0.01 1.08 ± 0.01 25 103215.33 ± 4064.81 2.96 ± 0.02 3.28 ± 0.01 1.06 ± 0.01 30 84204.33 ± 1351.77 3.22 ± 0.01 3.14 ± 0.01 1.07 ± 0.00 35 71067.67 ± 170.42 3.40 ± 0.02 2.98 ± 0.01 1.08 ± 0.00 40 62570.67 ± 2104.56 3.49 ± 0.02 2.83 ± 0.01 1.08 ± 0.00 45 60890.67 ± 896.68 3.55 ± 0.02 2.67 ± 0.01 1.09 ± 0.00 μ - 63 -